Femasys is trading at $2.44, down 12.23% in pre-market amid broader risk-off sentiment; no fresh company-specific announcement was identified for September 14, 2026.
- Latest company news was a September 9 CapexMD partnership expanding financing access for FemaSeed and related fertility products.
- Nasdaq futures are down 1.84% and the S&P 500 is down 0.67% amid AI-safety concerns, higher oil prices, and rate uncertainty.
- Femasys closed at $2.78 on September 11, 2026.